Recommend a Correction.
Throughout a Sunday morning interview on FOX & & Friends, Dr. Marc Siegel revealed that officials are in the first stage of evaluating a speculative COVID-19 pill called Molnupiravir.
It might be the holy grail on this because it was simply studied in phase 2 trials and it actually stopped the infection in its tracks, he stated during the interview. And there wasn t any virus found in the clients that were studied.
Dr. Siegel told the news outlet that the drug has actually revealed appealing signs of efficiency in minimizing COVID-19.
New York City (WJW) Medical researchers are evaluating a new medication that could be utilized to deal with COVID-19.
Associated video: More than 40 people given coronavirus treatment instead of vaccine.
It is possible that Molnupiravir might be available on the market within four to 5 months.
Molnupiravir apparently functions as a five-day, at-home treatment. It would be used to stop the coronavirus from reproducing before causing significant damage.
Suggest a Correction.